AURX Nuo Therapeutics, Inc.
Fundamentals / CIK 0001091596 / USDNuo Therapeutics, Inc. reported $6.03M in revenue and a net loss of $1.90M for the trailing twelve months ended September 30, 2026 (up 80.8% year over year), with a 64.6% gross margin and a -26.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AURX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$6.03M +80.8% YoY
-
Operating Income TTM-$1.57M -26.0% margin
-
Net Income TTM-$1.90M -31.5% net margin
-
Diluted EPS TTM-- Split-adjusted
-
Free Cash Flow TTM-$2.11M -34.9% FCF margin
-
Cash & ST Investments Sep 30, 2026$81K Total debt: $41K
Annual revenue and net income
10 fiscal years (2015 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.31M | $1.37M | $609K | $112K | $0 | $0 | $146K | $1.37M | $721K | $11.51M |
| Cost of Revenue | $1.10M | $303K | $126K | $19K | $0 | $0 | $115K | $163K | $1.09M | $7.97M |
| Gross Profit | $2.22M | $1.06M | $482K | $93K | $0 | $0 | $32K | $1.21M | -$370K | $3.54M |
| Research & Development | -- | -- | -- | -- | $0 | $0 | $181K | $576K | $1.33M | $2.55M |
| Selling, General & Admin | $4.73M | $3.52M | $3.65M | $3.41M | $91K | $378K | $820K | $2.14M | $4.54M | $15.26M |
| Total Operating Expenses | $4.73M | $3.52M | $3.65M | $3.41M | $91K | $378K | $1.00M | $2.71M | $15.16M | $44.86M |
| Operating Income | -$2.52M | -$2.46M | -$3.17M | -$3.32M | -$91K | -$378K | -$969K | -$1.50M | -$15.53M | -$41.32M |
| EBITDA | -$2.43M | -$2.43M | -$3.15M | -$3.31M | -$91K | -$378K | -$879K | -$1.40M | -$14.42M | -$40.58M |
| Interest Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $28K |
| Interest Expense | -- | -- | -- | -- | $0 | $48K | $221K | $39K | $11K | $39.31M |
| Income Before Tax | -$2.51M | -$2.32M | -$3.17M | -$3.17M | -$91K | -$91K | -$1.19M | -$1.54M | -$14.98M | -$52.90M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- | -$89K |
| Net Income | -$2.51M | -$2.32M | -$3.17M | -$3.17M | -$91K | -$91K | -$1.19M | -$1.54M | -$14.98M | -$52.81M |
| Basic EPS | -$0.05 | -$0.05 | -$0.08 | -$0.08 | -$0.03 | $0.30 | -$0.05 | -$0.07 | -$1.02 | -$0.42 |
| Diluted EPS | -- | -- | -- | -- | -$0.03 | $0.27 | -$0.05 | -$0.07 | -$1.02 | -$0.42 |
| Basic Shares Outstanding | 47.3M | 45.4M | 42.1M | 40.0M | 30.3M | 25.7M | 23.7M | 23.3M | 14.6M | 126.0M |
| Diluted Shares Outstanding | -- | -- | -- | -- | 30.3M | 27.3M | 23.7M | 23.3M | 14.6M | 126.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.87M | $1.77M | $1.30M | $1.10M | $1.03M | $700K | $484K | $395K |
| Cost of Revenue | $673K | $599K | $452K | $408K | $407K | $159K | $121K | $86K |
| Gross Profit | $1.19M | $1.17M | $850K | $688K | $625K | $541K | $363K | $308K |
| Selling, General & Admin | $1.57M | $1.34M | $1.30M | $1.27M | $1.17M | $1.19M | $1.11M | $938K |
| Total Operating Expenses | $1.57M | $1.34M | $1.30M | $1.27M | $1.17M | $1.19M | $1.11M | $938K |
| Operating Income | -$374K | -$167K | -$446K | -$579K | -$540K | -$652K | -$745K | -$629K |
| EBITDA | -$374K | -$140K | -$424K | -$555K | -$517K | -$629K | -$730K | -$618K |
| Net Income | -$425K | -$278K | -$618K | -$578K | -$538K | -$650K | -$746K | -$497K |
| Basic EPS | -$0.01 | -$0.01 | -$0.01 | -- | -$0.01 | -$0.01 | -$0.02 | -- |
| Basic Shares Outstanding | 48.5M | 48.4M | 48.3M | -- | 47.5M | 46.8M | 46.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 | Dec 31 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $549K | $284K | $929K | $2.05M | $1.41M | $148K | $152K | $157K | $161K | $0 |
| Cash & Short-Term Investments | $549K | $284K | $929K | $2.05M | $1.41M | $148K | $152K | $157K | $161K | $0 |
| Accounts Receivable, Net | $562K | $248K | $251K | $92K | $0 | -- | $0 | $0 | $0 | -- |
| Inventory | $214K | $150K | $210K | $240K | $0 | -- | -- | -- | -- | -- |
| Total Current Assets | $1.38M | $842K | $1.56M | $2.63M | $1.47M | $150K | $153K | $157K | $161K | $0 |
| Property, Plant & Equipment, Net | $366K | $177K | $45K | $53K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Assets | $466K | $348K | $314K | $412K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $1.85M | $1.19M | $1.88M | $3.05M | $1.47M | $150K | $153K | $157K | $161K | $0 |
| Accounts Payable | $436K | $219K | $395K | $398K | $527K | $526K | $522K | $520K | $518K | $536K |
| Deferred Revenue (Current) | $300K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $1.31M | $578K | $675K | $600K | $673K | $672K | $669K | $667K | $665K | $1.03M |
| Long-Term Debt | -- | -- | -- | -- | $0 | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $975K | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $1.50M | $97K | $164K | $256K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.80M | $676K | $839K | $856K | $673K | $672K | $669K | $667K | $665K | $1.03M |
| Total Debt (incl. Leases) | $97K | $164K | $256K | $335K | $0 | -- | -- | -- | -- | -- |
| Common Stock | $4.8K | $4.7K | $4.4K | $4.2K | $3.7K | $3.0K | $3.0K | $3.0K | $3.0K | $2.4K |
| Retained Earnings | -$34.77M | -$32.26M | -$29.94M | -$26.76M | -$23.59M | -$23.52M | -$23.51M | -$23.51M | -$23.50M | -$23.27M |
| Total Stockholders' Equity | -$957K | $514K | $1.04M | $2.19M | $793K | -$523K | -$516K | -$509K | -$504K | -$1.03M |
| Total Equity | -$957K | $514K | $1.04M | $2.19M | $793K | -$523K | -$516K | -$509K | -$504K | -$1.03M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $81K | $449K | $264K | $549K | $515K | $316K | $56K | $284K |
| Cash & Short-Term Investments | $81K | $449K | $264K | $549K | $515K | $316K | $56K | $284K |
| Accounts Receivable, Net | $1.41M | $1.17M | $874K | $562K | $652K | $320K | $277K | $248K |
| Inventory | $330K | $270K | $249K | $214K | $202K | $166K | $99K | $150K |
| Total Current Assets | $1.98M | $1.99M | $1.52M | $1.38M | $1.46M | $853K | $602K | $842K |
| Property, Plant & Equipment, Net | $705K | $572K | $345K | $366K | $347K | $370K | $392K | $177K |
| Total Non-Current Assets | $746K | $633K | $425K | $466K | $465K | $506K | $545K | $348K |
| Total Assets | $2.73M | $2.63M | $1.95M | $1.85M | $1.93M | $1.36M | $1.15M | $1.19M |
| Accounts Payable | $757K | $563K | $385K | $436K | $492K | $313K | $662K | $219K |
| Deferred Revenue (Current) | $381K | $312K | $312K | $300K | $300K | $300K | $200K | $0 |
| Total Current Liabilities | $2.45M | $1.55M | $1.37M | $1.31M | $1.26M | $999K | $1.28M | $578K |
| Deferred Revenue (Non-Current) | $952K | $857K | $935K | $975K | $1.05M | $1.12M | -- | $0 |
| Total Non-Current Liabilities | $2.12M | $2.61M | $1.96M | $1.50M | $1.09M | $1.19M | $79K | $97K |
| Total Liabilities | $4.58M | $4.16M | $3.33M | $2.80M | $2.35M | $2.18M | $1.36M | $676K |
| Total Debt (incl. Leases) | $41K | $60K | $79K | $97K | $115K | $132K | $148K | $164K |
| Common Stock | $4.9K | $4.8K | $4.8K | $4.8K | $4.8K | $4.7K | $4.7K | $4.7K |
| Retained Earnings | -$36.09M | -$35.67M | -$35.39M | -$34.77M | -$34.19M | -$33.66M | -$33.01M | -$32.26M |
| Total Stockholders' Equity | -$1.85M | -$1.54M | -$1.38M | -$957K | -$420K | -$825K | -$213K | $514K |
| Total Equity | -$1.85M | -$1.54M | -$1.38M | -$957K | -$420K | -$825K | -$213K | $514K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$2.51M | -$2.32M | -$3.17M | -$3.17M | -$91K | -$91K | -$1.19M | -$1.54M | -$14.98M | -$52.81M |
| Depreciation & Amortization | $85K | $23K | $15K | $6.8K | $0 | $0 | $90K | $102K | $1.11M | $741K |
| Stock-Based Compensation | $86K | $57K | $22K | $9.1K | $14K | $334K | $50K | $7.1K | $54K | $783K |
| Change in Receivables | -$405K | -$77K | -$318K | -$92K | $0 | $0 | $22K | -- | -- | -- |
| Change in Inventory | -$83K | $29K | $14K | -$240K | $0 | $0 | $25K | -$5.3K | $19K | $272K |
| Change in Payables | $217K | -$42K | -$3.2K | $18K | $8.1K | -$30K | $101K | $57K | -$12K | -$811K |
| Operating Cash Flow | -$865K | -$2.23M | -$3.17M | -$3.71M | -$120K | -$54K | -$922K | -$874K | -$4.90M | -$14.39M |
| Capital Expenditure | -$275K | -$155K | -$7.2K | -$60K | $0 | $0 | $0 | -- | -- | -$698K |
| Free Cash Flow | -$1.14M | -$2.39M | -$3.18M | -$3.77M | -$120K | -$54K | -$922K | -- | -- | -$15.09M |
| Investing Cash Flow | -$275K | -$155K | -$7.2K | -$60K | $0 | $0 | $0 | $2.0K | $1.9K | -$629K |
| Common Stock Issued | $791K | $1.50M | $2.00M | -- | $0 | $195K | $0 | $500K | $2.92M | $0 |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -- | -$471 | -- |
| Financing Cash Flow | $1.40M | $1.74M | $2.00M | $4.46M | $1.37M | $195K | $305K | $816K | $2.92M | $0 |
| Net Change in Cash | $265K | -$645K | -$1.18M | $692K | $1.25M | $141K | -$617K | -$57K | -$1.98M | -$15.02M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$425K | -$278K | -$618K | -$578K | -$538K | -$650K | -$746K | -$497K |
| Depreciation & Amortization | $612 | $26K | $22K | $24K | $23K | $23K | $15K | $12K |
| Stock-Based Compensation | $89K | $41K | $24K | $24K | $20K | $23K | $19K | $30K |
| Change in Receivables | -$322K | -$294K | -$312K | $41K | -$361K | -$44K | -$41K | $19K |
| Change in Inventory | -$61K | -$21K | -$35K | -$22K | -$36K | -$67K | $42K | $17K |
| Change in Payables | $194K | $178K | -$51K | -$56K | $179K | -$349K | $443K | -$33K |
| Operating Cash Flow | -$195K | -$236K | -$784K | -$423K | -$707K | $262K | $1.8K | -$491K |
| Capital Expenditure | -$174K | -$253K | -$847 | -$43K | $0 | -$1.7K | -$230K | $0 |
| Free Cash Flow | -$368K | -$490K | -$785K | -$466K | -$707K | $261K | -$228K | -$491K |
| Investing Cash Flow | -$174K | -$253K | -$847 | -$43K | $0 | -$1.7K | -$230K | $0 |
| Financing Cash Flow | $0 | $675K | $500K | $500K | $905K | $0 | $0 | $90K |
| Net Change in Cash | -$368K | $185K | -$285K | $34K | $198K | $261K | -$228K | -$400K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.9% | 77.8% | 79.3% | 82.9% | -- | -- | 21.6% | 88.1% | -51.3% | 30.8% |
| Operating Margin | -76.0% | -180.0% | -520.6% | -2958.2% | -- | -- | -663.0% | -109.8% | -2154.4% | -359.0% |
| Net Profit Margin | -75.8% | -170.2% | -521.2% | -2825.6% | -- | -- | -817.4% | -112.5% | -2077.4% | -458.8% |
| Return on Equity (ROE) | -- | -452.3% | -305.2% | -144.7% | -11.4% | -- | -- | -- | -3102.0% | -- |
| Return on Assets (ROA) | -136.1% | -195.4% | -168.9% | -104.1% | -6.2% | -56.3% | -432.1% | -158.1% | -1051.8% | -746.5% |
| Current Ratio | 1.06x | 1.45x | 2.32x | 4.39x | 2.18x | 0.24x | 0.19x | 0.82x | 1.27x | 0.07x |
| Quick Ratio | 0.89x | 1.19x | 2.01x | 3.99x | 2.18x | 0.24x | 0.01x | 0.80x | 1.23x | 0.07x |
| Debt to Equity | -- | 0.32x | 0.25x | 0.15x | 0.00x | -- | -- | -- | 0.00x | -- |
| Revenue Growth (YoY) | +142.7% | +124.3% | +442.1% | -- | -- | -100.0% | -89.3% | +90.1% | -- | +48.3% |
| Gross Profit Growth (YoY) | +108.8% | +120.2% | +418.5% | -- | -- | -100.0% | -97.4% | -- | -- | +257.5% |
| EPS Growth (YoY) | -- | -- | -- | -- | -110.0% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -- | +387.7% | -75.4% | -94.3% | -- | -100.0% | -90.4% | -47.3% | -61.9% | -- |
| 10Y Revenue / Share Growth | -23.4% | -53.3% | -87.0% | -97.8% | -100.0% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.6% | 64.1% | 65.5% | 66.9% | 70.4% | 76.0% | 76.9% | 77.8% |
| Operating Margin | -26.0% | -33.3% | -53.7% | -76.0% | -98.3% | -133.5% | -154.4% | -180.0% |
| Net Profit Margin | -31.5% | -38.7% | -57.7% | -75.8% | -93.1% | -126.7% | -146.2% | -170.2% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -- | -452.3% |
| Return on Assets (ROA) | -69.6% | -76.6% | -122.6% | -136.1% | -126.1% | -181.7% | -205.9% | -195.4% |
| Current Ratio | 0.81x | 1.28x | 1.11x | 1.06x | 1.16x | 0.85x | 0.47x | 1.45x |
| Quick Ratio | 0.67x | 1.11x | 0.93x | 0.89x | 1.00x | 0.69x | 0.39x | 1.19x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | -- | 0.32x |
| Revenue Growth (YoY) | +80.8% | +152.6% | +168.8% | +177.8% | +178.2% | +92.0% | +106.5% | +100.4% |
| Gross Profit Growth (YoY) | +90.7% | +116.3% | +133.9% | +123.2% | +131.2% | +80.6% | +97.5% | +98.2% |
| Operating Cash Flow Growth (YoY) | -- | -190.1% | -43073.8% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -287.8% | -- | -- | -- | -- | -- | -- |